sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group, Inc. Discloses Position in Spire Healthcare
The Vanguard Group, Inc. has filed a Form 8.3 disclosure concerning its interests in Spire Healthcare Group plc's securities. According to the release dated May 18, 2026, Vanguard holds 14,446,326 ordinary shares in Spire, representing a 3.59% stake. This disclosure is in line with Rule 8.3 of the Takeover Code, which mandates disclosure for those possessing 1% or more of relevant securities.
The filing indicates no additional deals aside from the reported holding. On May 15, 2026, Vanguard sold 5,490 ordinary shares at a price of 2.27 GBP each. There are no recent developments in derivatives or options related to this transaction. The announcement confirms there are no agreements or understandings pertaining to indemnity or voting rights.
R. H.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.